| For: | Zeki SS, Haidry R, Justo-Rodriguez M, Lovat LB, Wright NA, McDonald SA. Squamous cell carcinoma after radiofrequency ablation for Barrett's dysplasia. World J Gastroenterol 2014; 20(15): 4453-4456 [PMID: 24764687 DOI: 10.3748/wjg.v20.i15.4453] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i15/4453.htm |
| Number | Citing Articles |
| 1 |
Fahire Goknur Akarca, Nicholas J Shaheen, Matthew D Stachler. Does radiofrequency ablation of the lower oesophagus allow for clonal expansion of highly mutated neosquamous epithelium?. BMJ Oncology 2023; 2(1): e000089 doi: 10.1136/bmjonc-2023-000089
|
| 2 |
Hala El‐Zimaity, Vincenzo Di Pilato, Maria Novella Ringressi, Iva Brcic, Shanmugarajah Rajendra, Rupert Langer, Bastian Dislich, Monika Tripathi, Maha Guindi, Robert Riddell. Risk factors for esophageal cancer: emphasis on infectious agents. Annals of the New York Academy of Sciences 2018; 1434(1): 319 doi: 10.1111/nyas.13858
|
| 3 |
Edward Young, Joseph Fantasia, Eugene Phan, Rajvinder Singh. Endoscopic Treatment for Early Barrett’s Neoplasia: A Western Perspective. Digestion 2025; : 1 doi: 10.1159/000548561
|
| 4 |
Avyakta Kallam, Benjamin R Alsop, Prateek Sharma. Limitations of endoscopic ablation in Barrett’s esophagus. Expert Review of Gastroenterology & Hepatology 2015; 9(4): 487 doi: 10.1586/17474124.2015.976554
|
| 5 |
Tanmayee Benjamin, Prashanthi N. Thota. Synchronous or Metachronous Occurrence of Lesions of Different Histologic Types in Patients With Esophageal Cancer. Clinical Gastroenterology and Hepatology 2017; 15(5): 780 doi: 10.1016/j.cgh.2016.11.031
|
